期刊文献+

褪黑素对免疫性肝纤维化大鼠抗氧化酶活性的影响 被引量:5

Effects of MT on antioxidative enzymes activities in IHF rats induced by human albumine
下载PDF
导出
摘要 目的 研究褪黑素对免疫性肝纤维化大鼠血清及肝匀浆中SOD、GSHpx活性的影响。 方法 采用人血清白蛋白诱导大鼠免疫性肝纤维化模型 ,实验大鼠分为正常组、模型组、褪黑素预防组及阳性药对照组 ,检测各组动物血清及肝匀浆中SOD、GSHpx活性。结果 模型大鼠血清及肝匀浆中SOD、GSHpx活性明显降低 ;而自造模的尾静脉攻击阶段起 ,每天ig褪黑素 (0 3、0 6、0 9mg·kg-1) ,均可恢复模型大鼠血清及肝匀浆中SOD、GSHpx的活性。结论 褪黑素对免疫性肝纤维化大鼠模型具有一定程度的保护作用 ,其机制可能与增强其抗氧化酶活性有关。 e Objective To investigate the effects of melatonin(MT) on antioxidative enzymes activities in IHF rats induced by human albumine. Methods The rat immune hepatic fibrosis(IHF) model was induced by human albumine and the activitise of superoxide dismutase(SOD) and glutathione peroxidase(GSHpx) were determined by spectrophotometry. Results MT(0 3、0 6、0 9 mg·kg -1 ) was given daily (ig) for 9 weeks during the attacking stages. The results showed that MT reversed the decreased SOD and GSHpx activities in liver and serum. Conclusion MT has certain effects on the rats with IHF, its mechanisms may be related to the ability of scavenging free radicals.
出处 《安徽医科大学学报》 CAS 2001年第3期184-185,共2页 Acta Universitatis Medicinalis Anhui
基金 国家博士创新项目 (编号 98 90 1 0 6 5 2 )
关键词 褪黑激素 免疫性肝硬化 氧化还原酶类 大鼠 melatonia/pharmacol liver cirrhosis/immunology oxidoreductases rats
  • 相关文献

参考文献2

二级参考文献3

  • 1李健军,中华医学杂志,1988年,68卷,372页
  • 2郑少雄,中华医学检验杂志,1986年,31卷,36页
  • 3侯建存,免疫化学技术,1980年

共引文献144

同被引文献41

  • 1李志红,田德禄,叶永安,王玉忠,吕运海,李永华,安勇,苏良.酒精性肝纤维化阶段饮酒量与发病相关性初探[J].中国医刊,2005,40(6):35-36. 被引量:7
  • 2王吉耀 刘建军.肝纤维化[A].见:王吉耀主编.现代肝病治疗理论与进展[C].上海:上海医科大学出版社,1999.98~122.
  • 3钱白音 魏伟 徐叔云.褪黑素对大鼠免疫性肝纤维化的影响[J].安徽医科大学学报,1999,34(6):457-457.
  • 4Kono H, Rusyn I, Yin M et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest, 2000;106(7) :867-72.
  • 5Reiter RJ, Melchiorri D, Sewerynek E et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res,1995;18(1):1-11.
  • 6Yu MC,Yuan JM.Environmental factors and risk for hepatocellular carcinoma.Gastroenterology 2004;127(5 Suppl 1):S72-8.
  • 7Karsan HA,Rojter SE,Saab S.Primary prevention of cirrhosis.Public health strategies that can make a difference.Postgrad Med 2004;115(1):25-30.
  • 8Mendez-Sanchez N,Almeda-Valdes P,Uribe M.Alcoholic liver disease.An update.Ann Hepatol 2005;4(1):32-42.
  • 9Parola M,Robino G.Oxidative stress-related molecules and liver fibrosis.J Hepatol 2001;35(2):297-306.
  • 10Leevy CB,Elbeshbeshy HA.Immunology of alcoholic liver disease.Clin Liver Dis 2005;9(1):55-66.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部